GREY:TBPMQ - Post by User
Post by
SamV21on Feb 07, 2022 1:59pm
100 Views
Post# 34405624
Once again Tetra left in the dust on shareholders $$$
Once again Tetra left in the dust on shareholders $$$ - VBI-S is an intravenously injectable fluid currently under Phase II clinical evaluation for hypovolemia treatment due to sepsis/septic shock.
- CYT107 is a biological product naturally made by the body that may stimulate the immune system to destroy tumour cells. The drug is in phase II of clinical trials for the treatment of sepsis.
- SY 005 is a dianexin based therapeutics being developed by Lawson Health Research Institute and Yabao Pharmaceuticals to treat Sepsis. In April 2019, Suzhou initiated phase I, a clinical study to evaluate the safety, tolerance and pharmacokinetics of SY-005.
- HY 209 is a gel formulation of taurodeoxycholic acid, a G protein-coupled receptor 19 (GPCR19) agonist for sepsis treatment. The drug is currently under phase I of clinical trials for the treatment of sepsis.